Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 32,716Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Tygacil

PharmaCompass

01

Brand Name : Tygacil

Tigecycline

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Tygacil

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Tigecycline

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2019 Revenue in Millions : 197

2018 Revenue in Millions : 249

Growth (%) : -21

blank

02

Brand Name : Tygacil

Tigecycline

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Tygacil

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Tigecycline

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 200

2020 Revenue in Millions : 160

Growth (%) : 25

blank

03

Brand Name : Tygacil

Tigecycline

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

04

Brand Name : Tygacil

Tigecycline

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Tygacil

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Tigecycline

Main Therapeutic Indication : Anti-bacterial

Currency : USD

2015 Revenue in Millions : 323

2014 Revenue in Millions : 304

Growth (%) : -6%

blank

05

Brand Name : Tygacil

Tigecycline

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Tygacil

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Tigecycline

Main Therapeutic Indication : Anti-Bacterial

Currency : USD

2016 Revenue in Millions : 274

2015 Revenue in Millions : 304

Growth (%) : -10

blank

06

Brand Name : Tygacil

Tigecycline

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Tygacil

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Tigecycline

Main Therapeutic Indication : Anti-bacterial

Currency : USD

2017 Revenue in Millions : 260

2016 Revenue in Millions : 274

Growth (%) : -5

blank

07

Brand Name : Tygacil

Tigecycline

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Tygacil

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Tigecycline

Main Therapeutic Indication : Anti-Bacterial

Currency : USD

2018 Revenue in Millions : 248

2017 Revenue in Millions : 260

Growth (%) : -5%

blank